Atlas Trials

Study of the Safety and Leukostimulatory Activity of the Preparation "Panagen" in Patients With Breast Cancer

Clinical trial NCT02115984 · COMPLETED

Trial details

NCT number
NCT02115984
Sponsor
Panagen, Limited Liability Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2010-05-01
Primary completion
2012-05-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.